Nottingham Advisors Inc. cut its holdings in shares of Vanguard Small-Cap ETF (NYSEARCA:VB – Free Report) by 90.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 873 shares of the company’s stock after selling 7,932 shares during the period. Nottingham Advisors Inc.’s holdings in Vanguard Small-Cap ETF were worth $250,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of VB. Wellington Altus USA Inc. bought a new position in Vanguard Small-Cap ETF during the 2nd quarter valued at about $28,000. James T. Borello RIA bought a new stake in shares of Vanguard Small-Cap ETF in the third quarter worth approximately $26,000. Balance Wealth Partners LLC bought a new stake in shares of Vanguard Small-Cap ETF in the third quarter worth approximately $28,000. Scarborough Advisors LLC bought a new stake in shares of Vanguard Small-Cap ETF in the first quarter worth approximately $39,000. Finally, WPG Advisers LLC raised its holdings in shares of Vanguard Small-Cap ETF by 37.7% during the third quarter. WPG Advisers LLC now owns 168 shares of the company’s stock valued at $48,000 after purchasing an additional 46 shares during the last quarter.
Vanguard Small-Cap ETF Stock Up 0.6%
VB opened at $291.80 on Tuesday. The stock has a market capitalization of $78.93 billion, a price-to-earnings ratio of 18.27 and a beta of 1.06. The firm has a 50 day moving average price of $291.68 and a 200-day moving average price of $286.27. Vanguard Small-Cap ETF has a twelve month low of $241.17 and a twelve month high of $309.51.
Vanguard Small-Cap ETF Company Profile
The Vanguard Small-Cap ETF (VB) is an exchange-traded fund that is based on the CRSP US Small Cap index. The fund tracks the CRSP US Small Cap Index. The market-cap-weighted index includes the bottom 2-15% of the investable universe. VB was launched on Jan 26, 2004 and is managed by Vanguard.
Read More
- Five stocks we like better than Vanguard Small-Cap ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Vanguard Small-Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Small-Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.
